PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pulmonary and Critical Care Medicine, Department of Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ. Electronic address: jr1106@rwjms.rutgers.edu.\', \'Department of Pharmacy Practice and Administration, Rutgers-Ernest Mario School of Pharmacy, New Brunswick, NJ.\', \'Division of Infectious Disease, Department of Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0012-3692(20)30764-910.1016/j.chest.2020.04.024
?:doi
?:hasPublicationType
?:journal
  • Chest
is ?:pmid of
?:pmid
?:pmid
  • 32343968
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.524
?:rankingScore_hIndex
  • 261
is ?:relation_isRelatedTo_publication of
?:title
  • Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all